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Medicated cotton crepe bandages have been developed, using natural curcumin conjugated polymer nanoparticle with 
biocompatible and biodegradable properties. Curcumin (C) has been incorporated into Chitosan (Ch) and sodium alginate 
(A) microcapsule, which serve as templates for nanofibres. The coating of C-ChA results in chitosan scaffold (CS) 
containing curcumin-chitosan microcomplex (CS-CChM). Both the substances act as a powerful biomaterial for tissue 
engineering applications, especially for wound healing. CS-CChM along with C-ChA have been characterized using FTIR 
and SEM. The free radical scavenging effect is determined by DPPH (2,2-diphenyl-1-picrylhydrazyl) and anti-inflammatory 
assay. The developed CS-CChM nanofibre shows an impressive mechanical stability which is an essential requirement  
for wound healing. The bearing of curcumin shows cytotoxic effect. The in vitro radical scavenging activity and the  
anti-inflammatory assay are performed by inhibition of albumin denaturation. These microencapsulated matrix displays 
potent anticancer activity against mouse fibroblast on both normal (L929) and human lung adenocarcinoma (A549) cells. 
The cell viability is observed to be 51.4 ± 0.71 and 30.53 ± 0.99 respectively for both. CS-CChM nanofibre is found to be 
stable against enzymatic degradation, which is the most important parameter for promoting the proliferation of cells, 
contributing to repair and remodeling of tissues during wound healing applications.  
Keywords: Antioxidant, Anti-inflammatory, Biodegradable, Curcumin, Chitosan, Cytotoxicity, 2,2-diphenyl-1-
picrylhydrazyl, Radical scavenging activity 
1 Introduction 
Natural products, embracing the bioactive 
ingredients, play a vital role in exhibiting their 
therapeutic properties
1
. Curcumin is a phenolic 
compound, extracted from the turmeric plant and 
mainly used as an essential coloring substance, which 
can absorb the visible light at a wavelength range 
420–425 nm. Curcumin has a variety of biological 
activities and pharmacological actions, such as  
anti-inflammatory, anti-carcinogenic and anti-virus 
properties, as well as promising clinical applications 
due to its low toxicity
2
. In recent years, curcumin has 
been shown to inhibit cell proliferation in a variety of 
human cancer cell lines in vitro and has been used 
both to prevent and treat various cancers in vivo. 
However, it has extremely low aqueous solubility and 
shows rapid intestinal and hepatic metabolism, which 
results in poor systemic bio-availability and restricts 
its oral use
3
. The bacterial infection is a major 
problem in recent days and it interferes with wound 
healing process that may lead to life threatening 
complications. To overcome this problem, a new 
modern therapeutic nano coated drug for wound 
healing properties has been developed
4
. 
Chitosan and alginate are well known for accelerating 
the healing of wounds in humans. Chitosan (Ch), a 
natural cationic polymer, is biologically renewable, 
biodegradable, biocompatible, non-antigenic, nontoxic, 
and biofunctional, and it can accelerate the wound 
healing process enhancing the functions of inflammatory 
cells, macrophages, and fibroblasts. The advantages 
of these biomaterials can be easily processed into 
different forms, such as membrane, sponges, gels, 
scaffolds, microparticles, nanoparticles and nanofibre 
for a variety of biomedical applications such as drug 
delivery, gene therapy, tissue engineering and wound 
healing
5
. In medicine, it may be useful in bandages to 
reduce bleeding and as an antibacterial agent; it can 
also be used to help deliver drugs through the skin. 
Alginate, an anionic polymer, is also biocompatible, 
hydrophilic, and biodegradable under normal 
physiological conditions. Both the polymers interact 
to form complexes through chemical binding
6
.  
This paper reports study on the preparation of 
curcumin encapsulated chitosan-alginate nanocapsules 
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for their antioxidant and anti-inflammatory activities on 
cotton crepe bandage to use against the pain and 
inflammation. Normally cotton crepe bandage is used 
for relieving pain by means of resting the muscles. 
However, the coating on cotton crepe bandage with 
curcumin increases its pain relieving property and also 
reduces the inflammatory response caused by the 
friction of bones. The cotton crepe bandage fabricated 
with the curcumin will be a great relief for the chronic 
arthritic patients. Furthermore, the chitosan as curcumin-
chitosan microcomplex coated into the belladonna 
plaster will enhance reduction in pain and inflammation. 
Normally the hansaplast is widely used for relieving 
pain by means of muscle stiffness, nerves swelling, joint 
swelling, mumps and boils. Coating the hansaplast with 
the chitosan scaffold containing curcumin-chitosan 
microcomplex increases its pain relieving property and 
reduces the inflammatory response. 
 
2 Materials and Methods 
 
2.1 Extraction of Curcuminoids  
The extraction of curcuminoids was done using the 
methodology as reported by Kulkarni
7
. Twenty gram 
(20 g) turmeric rhizome powder sample was taken 
into a thimble and placed in a soxhlet apparatus, 
which was set up with the mid polar methanol solvent 
(B P 65
o
C). Methanol (20mL) was added and extracted 
according to its boiling point for 7 h. After completion 
of extraction the dark brown extract was cooled, 
concentrated separately under reduced pressure using 
rotary evaporator and stored at -20˚C for further 
testing. The pure curcumin (1mg/mL) was used as 
standard. Finally, curcuminoids were analyzed by 
using a spectrophotometric method. The different 
concentrations (20, 40, 60, 80, 100µg/mL) of the 
sample were measured at 420 nm using UV – Visible 
spectrophotometer (Hitachi, U-2900).  
 
2.2 Preparation of Curcumin Loaded Chitosan-alginate  
(C-ChA) 
The chitosan powder (0.2g) in 20mL of acetic acid 
solution (0.5 % w/v), sodium alginate powder (0.2g) 
was dissolved in 20mL of deionized water. The 
solution was mixed in different ratios such as 1:1, 2:1 
and 3:1 and blended with a homogenizer until an 
opaque aqueous solution was obtained. Then the 
curcumin was accurately weighed and dissolved in 
absolute methanol. The dissolved curcumin was 
conjugated with chitosan- alginate. The solution was 
centrifuged to remove the trapped air bubbles. Finally, 
the air bubble-free solution was poured into the petri 
plates, frozen overnight at -40°C, and then lyophilized 
at 35°C for 24 h in a freeze dryer.  
Fabrication of chitosan matrix was done using  
the method as followed by Amirthalingam et al
8
. 
Chitosan scaffold was fabricated by the freeze 
gelation method. Briefly, 2 g of chitosan was 
dissolved in 100 mL of acetic acid solution (2% w/v 
in water) and this polymer solution was allowed to 
freeze at -20ºC. The frozen chitosan solution was 
immersed in a pre-cooled NaOH and methanol 
solution for gelation of chitosan. Finally, the gelled 
chitosan was slowly dried at room temperature. The 
completely dried scaffold was taken in a petridish, 
and curcumin microcomplex (equivalent to 50mg) 
suspension in purified water was added onto the 
surface and slowly dried at room temperature to 
obtain chitosan scaffold containing curcumin- 
chitosan microcomplex (CS-CChM) particles. 
 
2.3 Characterization of C-ChA and CS-CChM 
FTIR measurements were performed using a Perkin 
Elmer 2000 spectrometer with Grams as the operating 
software to determine the functional groups present  
in the prepared curcumin, C-ChA and CS-CChM 
samples. The spectra were recorded in the  
frequency range of 4000−600 cm−1 on an infrared 
spectrophotometer (IR Prestige21, Shimadzu). The 
structure and composition of freeze-dried purified C-
ChA and CS-CChM were analyzed using a 10 kV 
ultra-high resolution SEM. The 25µL of sample was 
sputter coated on copper stub, and the images of 
curcumin coated chitosan were studied using an FEI 
QUANTA-200 SEM. 
 
2.4 DPPH Radical Scavenging Activity 
The free radical scavenging activity of curcumin 
encapsulated chitosan-alginate extract was measured 
in vitro by 1, 1-diphenyl-2-picryl-hydrazyl (DPPH) 
assay
9
. About 0.1mM solution of DPPH in 100% 
methanol was prepared, and 1mL of this solution was 
added to 500µL of C-ChA dissolved in methanol at 
different concentrations (20-60µg/mL). This mixture 
was shaken and allowed to stand at room temperature 
for 30 min in the dark and the absorbance was 
measured at 517nm using spectrophotometer. The 
IC50 value of drug was compared with that of ascorbic 
acid, which was used as standard. The capacity to 
scavenge the DPPH radicals was calculated using the 
following formula: 
 
DPPH scavenged (%) = (Control OD-Test OD) ×100 / 
                                       Control OD 
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2.5 Anti-inflammatory Activity  
The anti-inflammatory activity of test sample was 
studied by using inhibition of albumin denaturation 
technique
9
. The reaction mixture consists of the test 
extract at different concentration and 1% aqueous 
solution of bovine albumin fraction. pH of the 
reaction mixture was adjusted using a small amount 
of 1N HCl. Diclofenac sodium (10mg) was used as a 
standard drug. The samples were incubated at 37ºC 
for 20 min and then heated at 57ºC for 20 min. After 
cooling the samples, the turbidity was measured 
spectrophotometrically at 660 nm. The experiment 
was performed in triplicate. Percentage inhibition of 
protein denaturation was calculated as follows: 
 
% Inhibition = (Control OD-Test OD) × 100 /  
                         Control OD 
 
2.6 Fabrication of CS-CChM into Hansaplast and Crepe 
Bandage  
Fabrication of chitosan scaffold containing 
curcumin- chitosan microcomplex into hansaplast and 
crepe bandage respectively was done as per the 
method of Mohanty et al.
10
. CS-CChM hansaplast 
was prepared using 50µg in 20mL of methanol. The 
suspension of methanol and CS-CChM was coated 
into the belladonna plaster. The 50µg of curcumin 
encapsulated chitosan-alginate was incorporated into 
a fluid phase of 1.75mL of oleic acid. The mixture of 
Oleic acid containing curcumin encapsulated 
chitosan-alginate was coated into the cotton crepe 
bandage using the padding technique. 
 
2.7 Cell Line and Culturing  
The L929 - mouse fibroblast normal cell line and 
human lung adenocarcinoma (A549) cell line were 
purchased from National Centre for Cell Science 
(NCCS), Pune. Cells were maintained in the 
logarithmic phase of growth [minimum essential 
medium (MEM) with 10% FBS (GIBCO, USA), 100 
U/mL penicillin and 100µg/mL streptomycin] in a 
humidified atmosphere of 95% air and 5% CO2 at 
37˚C. Once the cells had covered about 80% of the 
surface, they were trypsinized and then adjusted using 
haemocytometer for anti-proliferative and cytotoxicity 
measurements.  
2.8 Cytotoxicity Assay 
The MTT [3-(4, 5-dimethythiazol-2-yl)- 2,5-
diphenyl tetrazolium bromide] assay was used to test 
the viability of the cells (3 × 10
5
/well). It was seeded 
in 96 well plates, incubated for overnight in CO2 
incubator. The cells were treated with various 
concentrations of CS-CChM and the cells were then 
washed with phosphate buffer saline (PBS). Next, 
50µL of MTT (5mg/mL) was added to each well, and 
the wells were incubated for 3 - 4 h at 37˚C. The 
purple, blue MTT formazan precipitate was dissolved 
in 100µL of Dimethyl sulfoxide (DMSO). The 
absorbance was measured on the ELISA reader at  
570 nm. The triplicate values were calculated using 
the following formula: 
 
% of cell viability = (OD of treated cells /  
                                 OD of control cells) × 100. 
 
2.9 Statistical Analysis 
Data, expressed as the Mean ± S.D using statistical 
software SPSS version 17.0, was used for the 
analysis. P value <0.05 was considered significant. 
 
3 Results and Discussion 
 
3.1 Extraction and Estimation of Curcuminoids 
Curcuminoids are extracted from the samples 
through “soxhlet extraction apparatus”. After drying 
the extract, the weight percentage of curcuminoids is 
calculated (Table 1). Kulkarni et al.
7
 obtained the 
maximum concentration of curcuminoids in the 
methanol extract in the form of yellowish orange 
color. Concentrations of the curcumin in the extracted 
dried sample are analyzed on spectrophotometer at 
420 nm with respect to standard curcumin. The 
wavelength at which maximum absorption takes  
place in UV spectrophotometer at 420nm has been 
obtained by Hazra et al
11
. The results show that the 
concentration of the curcumin is higher in rhizome 
turmeric (103mg) than in processed turmeric  
powder (76mg). Physicochemical characterization of 
chitosan-alginate interactions due to the positively 
charged chitosan and negatively charged sodium 
alginate have been studied for different blend ratio of 
chitosan-alginate (1:1, 2:1 and 3:1)
6
. 
Table 1 — Dry weight and percentage of curcumin from different turmeric powder samples 
Sample Solvent Dry wt. (in 20g turmeric)  
g 
Curcumin present in the 
extract, % 
Fresh rhizome turmeric powder Methanol 2.06 10.3 
Processed turmeric powder Methanol 1.92 9.6 
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3.2 Curcumin - incorporated Chitosan-alginate 
The curcumin-methanol solution is incorporated 
into the chitosan-alginate that shows highest intensity 
to prepare the curcumin loaded chitosan-alginate  
(C-ChA) [Fig. 1 (a)]. Chitosan acts as sustain drug 
carrier, and the curcumin helps in establishing wound 
healer, pain relieving and anti-inflammatory activity 
from the scaffold. The chitosan matrix is prepared by 
the freeze gelation method. The frozen chitosan 
polymer solution and gelling liquid are maintained at 
the same temperature to avoid sudden change in the 
temperature during the gelling process. The prepared 
chitosan scaffold is shown in Fig. 1 (b). The excess 
surface water from the gelled scaffold is carefully 
removed and the air is dried and stored at room 
temperature (37˚C). The chitosan support is developed 
and the results are found in agreement with the studies 
of Amirthalingam et al
8
. 
The curcumin microcomplex is attached with 
chitosan through physical interaction. Chitosan in the 
form of solid support could be converted into a  
drug delivery system by incorporating curcumin 
microcomplex in them. The curcumin released from 
the microcomplex incorporated scaffold would aid 
wound healing by controlling bacterial infections in 
the injured skin. The chitosan supported chitosan-
curcumin microcomplex (CS-CChM) was shown  
in Fig. 1 (c). In this study, the chitosan scaffold 
containing chitosan-curcumin microcomplex (CS-
CChM) has been prepared for evaluation of anti-
inflammatory, antioxidant and cytotoxic activity. 
 
3.3 FTIR Study 
The Fourier transform infrared (FTIR) spectra at 
different ratio of C-ChA are depicted in Fig. 2. The 
intensity of the characteristic peak is recorded high as 
3:1 (C-ChA) followed by ratios 2:1 and 1:1. This 
indicates that the degree of ionic interaction between 
the negatively charged carboxylic ion group of alginate 
and the positively charged amino group of chitosan  
in three different ratios of chitosan-alginate inter 
polyelectrolyte complex is different and found high in 
3:1 ratio of chitosan and alginate complex. In the FTIR 
spectrum, C-ChA (3:1 ratio, blue color peak) exhibits  
a peak at 3247 cm
−1
 due to amine C-H stretching 
(phenolic group), besides other peaks at 2925 cm
−1
 
(amine N-H stretching), 1654 cm
−1
 (aromatic (C=C) 
bending stretching and 603 cm
−1
 [primary amines 
strong halocompound (C-Br) stretching]. Further, the 
functional group of C-CA (2:1 ratio, green color peak) 
exhibits amide −NH and −OH stretching frequencies of 
the broad peak at 3407 cm
−1
 and 1070 cm
−1
 [strong 
sulfoxide (S=O)] stretching. Finally, C-CA (1:1 ratio, 
orange color peak) shows the peak at 3305 cm
−1
 for 
−NH stretching. Peaks for N-O stretching of nitro 
compound, and alkene (C=C) bending stretching are 
observed at 1542 cm
−1
. The peak at 971 cm
−1
 
corresponds to the presence of curcumin aromatic 
 
 
Fig. 1 — Curcumin encapsulated chitosan alginate coated microcomplex (a) curcumin incorporated into the chitosan (C-ChA), (b) 
chitosan scaffold, and (c) chitosan scaffold containing chitosan – curcumin microcomplex (CS – CChM) 
 
 
 
Fig. 2 — Comparative FTIR spectra of curcumin compounds 
incorporated with chitosan alginate at different ratios [3:1 blue 
color peak (C3A1), 2:1 green color peak (C2A1), 1:1 orange color 
peak (C1A1)] 
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(−C=C−) in C-ChA matrix. The alginate spectrum 
shows a characteristic band of carbonyl (C=O) at 1640 
cm
−1
 and 1424 cm
-1
, as also mentioned by Dai et al
12
.  
 
3.4 SEM Study 
The cross-sectional and surface morphology of the 
C-CA and CS-CChM shows the cubic structure with a 
size range of 35 - 65 nm. The CS-CCM nanofibres 
have the smooth surface and exhibits improved cell 
attachment and sufficient oxygen permeability for 
quick war time action in the skin regeneration 
process. The particle surface of the microcomplex is 
found to be smooth. Figure 3 shows SEM micrographs 
of C-ChA: (a) scale bar 1µm and magnification 
×10,000, (b) its surface morphology, scale bar 1µm 
and magnification ×20,000, (c) scale bar 0.5µm and 
magnification ×30,000, and (d) scale bar 0.2µm and 
magnification ×55,000. Similarly, Thi et al.
13
 reported 
that PF/Chi NPs loaded with curcumin shows that the 
particles are spherical and uniform. 
 
3.5 DPPH Radical Scavenging Activity 
DPPH in the presence of methanol produces stable 
free radical and accepts an electron or hydrogen radical 
to become a stable diamagnetic molecule. This study 
illustrates the hydrogen donating ability of C-ChA  
at various concentrations as compared to standard 
antioxidant (L- ascorbic acid). The model of scavenging 
the stable DPPH radical is a widely used method to 
evaluate antioxidant activities in a relatively short time 
as compared to other methods. The reduction capability 
of the DPPH radical is determined by the decrease  
in its absorbance at 517 nm, induced by curcumin 
encapsulated chitosan alginate. The IC50 value is 41.37 ± 
0.71 at 60 µg/mL of methanolic extract of C-ChA. 
Curcumin is well known to exhibit antioxidant property, 
as also reported by Das et al.
9
 Similarly, C-ChA also 
have the same antioxidant property at different 
concentrations (Fig. 4). 
It is reported that the oxidative stress occurs when 
the free radical formation exceeds the body’s capacity 
to protect itself and this contributes different biological 
chronic conditions, such as arteriosclerosis, arthritis, 
cancer, diabetes and various neuro-degenarations. The 
primary antioxidants react with free radicals, and this 
may limit free radical damage occurring in the human 
body
14
. The observation of this study supports the ability 
of C-ChA in protection against oxidative damage. 
 
3.6 Anti-inflammatory Activity 
Protein denaturation is a process in which proteins 
lose their tertiary structure and secondary structure by 
application of external stress or compound, such as a 
strong acid or base, a concentrated inorganic salt, an 
 
 
Fig. 3 — SEM micrographs of nanofibres (a) C-ChA (curcumin incorporated chitosan alginate) at × 10,000 & (b) C-ChA at ×30,000; and 
(c) CS-CChM (chitosan scaffold containing chitosan-Curcumin microcomplex) at ×10,000 & (d) CS-CChM at ×1000 magnification 
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organic solvent and heat. Most biological proteins 
lose their biological function when denatured. 
Denaturation of proteins is one of the well-defined 
causes of inflammation. Curcumin is well known for 
its anti-inflammatory property
14
, causing the similar 
anti-inflammatory property in the CS-CChM at 
different concentrations (Fig. 4). This CS-CChM have 
shown inhibition of thermally induced protein 
(albumin) denaturation in a dose dependent manner, 
where the IC50 value is 54.17 ± 0.28 in 60 µg/mL of 
methanolic extract of CS-CChM and diclofenac 
sodium is used as a standard. Since inflammation is 
one of the body’s nonspecific internal systems of 
defense, the response of a tissue to an accidental cut is 
similar to the response that results from other types of 
tissue damage, caused by burns due to heat, radiation, 
bacterial or viral invasion
15
. 
 
3.7 CS-CChM Coated into Hansaplast Fabrication 
Hansaplast contains 0.2% of Atropa belladonna 
extract. The healing power of belladonna activates 
body heat against pain reliefs from muscle stiffness, 
nerves swelling, joint swelling, mumps and boils. The 
curcumin loaded oleic acid based polymeric (COP) 
bandages was formulated by Hazra et al 
11
. Similarly, 
the CS-CChM coated into the hansaplast increases  
the relieving property against pain and inflammation. 
Control and fabricated with chitosan scaffold 
containing curcumin-chitosan microcomplex coated 
hansaplast are shown in Figs 5 (a) and (b). 
 
3.8 Fabrication of C-ChA Coated Cotton Crepe Bandage 
Cotton crepe bandage, used to reduce the arthritic 
pain when fabricated with C-ChA using padding 
technique, causes reduced inflammation and pain due 
to the enhanced antioxidant and anti-inflammatory 
activity of the prepared curcumin microcomplex. 
Crepe bandages both control and fabricated with 
curcumin encapsulated chitosan alginate are shown  
in Figs 5 (c) and (d). This study leads to fabricate 
curcumin microcomplex into crepe bandage and the 
construction of CS-CChM into the belladonna plaster 
for enhanced reduction in pain and inflammation
16
. 
 
3.9 Cytotoxicity Activity 
The cytotoxic effects of cell adhesion/proliferation, 
against normal mouse fibroblast (L929) cell line and 
cancer cell line (A549) are studied and the viability of 
chitosan coated curcumin scaffolds is investigated 
using phase contrast microscopy and MTT analysis. 
The results are also compared with normal and cancer 
cell lines. Some representative microscopic images of 
cultured L929 cells are shown in Figs 6 (a) and (b). 
The effect of chitosan coated curcumin scaffolds at 
different concentrations (5, 25, 50, 75 and 100µg/mL) 
and the maximum cell viability of L929 cells are 
studied at 48 h. Cytotoxicity against the mouse 
fibroblast cell line L929 shows maximum cell lysis at 
the concentration of 100µg/mL. The IC50 value is 
75µg/mL (51.49 ± 0.71), which indicates that such 
concentration could lyse 50% of L929 cell line after 
48 h incubation. This significantly decreases the cell 
viability in treating concentrations as compared to 
control (p < 0.05). Clearly, the MTT assay results 
reveal that the metabolic activity of L929 cells 
decreases with the lower concentration of extract in 
 
 
Fig. 4 — Free radical scavenging and anti-inflammatory activity 
 
 
 
Fig. 5 — Curcumin encapsulated chitosan-alginate fabricated 
cotton crepe bandage (a) control -front view of hansaplast;  
(b) fabricated with CS-CChM- back view of fabricated hansaplast; 
(c) control cotton crepe bandage; and (d) fabricated with C-ChA 
of fabricated cotton crepe bandage 
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chitosan coated curcumin matrix in vitro. Verma  
et al.
17 
reported that the normal cell lines at  
higher concentrations show significant cell  
mortality. Moreover, biocompatibility characteristics of 
Nepenthes khasiana mediated synthesized GNPs  
are evaluated against normal mouse fibroblasts 
(L929) cell lines
18
. 
In the present study the antiproliferation of 
chitosan coated curcumin scaffolds is made on cancer 
cell line A549 assessed by MTT assay. Dose–
dependent inhibitory concentrations are observed at 5, 
25, 50, 75 and 100µg/mL. The IC50 (50.03 ± 1.01) 
value for A549 cells is recorded using 25 μg/mL at  
24 h. The results are shown in Fig. 6 (c). There  
is a significant decrease in the cell viability in lower 
extract concentrations when compared to control  
(p < 0.05). The chitosan coated HA-DTX conjugate 
nanoparticles show effective cytotoxicity, causing 
human breast cancer (MCF-7) and 4 T1 cell  
lines, with inhibitory concentration (IC50) of 
45.34 μM and 354.25 μM respectively. On the other 
hand, 233.8 μM and 625.9 μM IC50 is observed for 
DTX on 4T1 and MCF-7 cell lines after 48 h 
incubation. DTX loaded chitosan nanoparticles are 
found more effective against cancer cells than free 
DTX drug
19
. 
 
4 Conclusion 
In this study, a C-ChA nanofibrous scaffold coated 
with curcumin has been prepared for wound healing 
application. FTIR and SEM reveal the structural 
characterization of C-CA and CS-CChM in a stable 
form. C-ChA coated on the cotton crepe bandage can 
be effectively used for arthritis against pain and 
inflammation. Similarly, the matrix can also be used 
for the above-said diseased condition and they do 
exhibit cytotoxicity to L929 (normal fibroblast cells) 
at higher concentration of curcumin, whereas 
cytotoxicity in cancer cell is achieved at a lower 
concentration itself, confirming the least toxicity of 
the prepared scaffold to normal cells at a very high 
concentration. Hence, the development of novel 
curcumin coated crepe bandage and chitosan coated 
scaffold is beneficial for use in diseased condition 
having inflammation in muscles and joints like 
arthritis. 
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